Sodertalje, Sweden

Lars-Inge Olsson



Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 57(Granted Patents)


Location History:

  • Södertälje, SE (2004)
  • Sodertalje, SE (1994 - 2012)

Company Filing History:


Years Active: 1994-2012

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Lars-Inge Olsson: A Pioneer in Pharmaceutical Innovations**

Introduction

Lars-Inge Olsson, an accomplished inventor based in Södertälje, Sweden, has made significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, he is recognized for his innovative approach to developing new therapeutic compounds that hold the potential to improve health outcomes.

Latest Patents

Olsson's recent patents include groundbreaking advancements in boron compounds, particularly their application in boron neutron capture therapy (BNCT). His invention relates to novel boron-comprising compounds and pharmaceutical compositions that utilize these compounds for therapeutic purposes. The significance of this innovation lies in its potential application in BNCT, which is a targeted radiation therapy.

In addition, he has developed compounds that serve as antibacterial agents. This invention focuses on nitric oxide-releasing derivatives of proton pump inhibitors, offering a new avenue for combating bacterial infections. The patent elaborates on the therapeutic use of these compounds, the formulation of pharmaceutical compositions, and processes for their preparation, alongside the mention of potential co-administration with other known medicaments.

Career Highlights

Throughout his career, Lars-Inge Olsson has worked with notable companies in the pharmaceutical industry, including Astra AB and Pharmacia AB. His experience in these organizations has greatly shaped his expertise and contributed to his innovative projects.

Collaborations

Olsson has collaborated with talented individuals such as Hubert Agback and Leif G Ahrgren, further enriching his work through cooperative efforts. These partnerships have likely facilitated the sharing of ideas and expertise, fostering an environment of innovation.

Conclusion

Lars-Inge Olsson exemplifies the spirit of innovation in the pharmaceutical sector. His latest patents not only highlight his capability as an inventor but also showcase his commitment to developing therapies that can significantly impact medical treatment. With his ongoing contributions, Olsson remains a key figure in the advancement of pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…